熱門資訊> 正文
Lexaria任命理查德·克里斯托弗为首席执行官
2024-09-05 22:49
- Lexaria Bioscience Corp Warrant 2020-12.01.26 on Lexaria Bioscience(LEXXW) 0
- Lexaria Bioscience Corp Ordinary Shares(LEXX) 0
- Lexaria Bioscience (NASDAQ:LEXX) on Thursday said Chief Executive Officer Chris Bunka is stepping aside for the appointment of Richard Christopher as new CEO, effective August 31, 2024.
- Most recently, Christopher was the CFO at InVivo Therapeutics. Prior to joining InVivo, Christopher was the CFO of iCAD.
- LEXX is +0.87% to $3.4701.
- Source: Press Release
More on Lexaria Bioscience Corp.
- Seeking Alpha’s Quant Rating on Lexaria Bioscience Corp.
- Historical earnings data for Lexaria Bioscience Corp.
- Financial information for Lexaria Bioscience Corp.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
